Heterologous SARS-CoV-2 Booster Vaccinations: Preliminary Report
The Washington Post reports in Johnson & Johnson recipients may benefit from a booster, but perhaps a different shot, new data suggests https://ift.tt/2X7oG16 "The documents include an FDA review of Johnson & Johnson's tests of a second dose of its own vaccine and a separate preprint study that tested mixing booster doses from different companies. The data could provide a road map for the 15 million people who received Johnson & Johnson vaccine in the United States, many of whom have felt left out because the vast majority of U.S. vaccine recipients received messenger RNA vaccines from Pfizer-BioNTech or Moderna." The preprint: https://ift.tt/3BACal0 0 comments on Hacker News.
The Washington Post reports in Johnson & Johnson recipients may benefit from a booster, but perhaps a different shot, new data suggests https://ift.tt/2X7oG16 "The documents include an FDA review of Johnson & Johnson's tests of a second dose of its own vaccine and a separate preprint study that tested mixing booster doses from different companies. The data could provide a road map for the 15 million people who received Johnson & Johnson vaccine in the United States, many of whom have felt left out because the vast majority of U.S. vaccine recipients received messenger RNA vaccines from Pfizer-BioNTech or Moderna." The preprint: https://ift.tt/3BACal0
The Washington Post reports in Johnson & Johnson recipients may benefit from a booster, but perhaps a different shot, new data suggests https://ift.tt/2X7oG16 "The documents include an FDA review of Johnson & Johnson's tests of a second dose of its own vaccine and a separate preprint study that tested mixing booster doses from different companies. The data could provide a road map for the 15 million people who received Johnson & Johnson vaccine in the United States, many of whom have felt left out because the vast majority of U.S. vaccine recipients received messenger RNA vaccines from Pfizer-BioNTech or Moderna." The preprint: https://ift.tt/3BACal0 0 comments on Hacker News.
The Washington Post reports in Johnson & Johnson recipients may benefit from a booster, but perhaps a different shot, new data suggests https://ift.tt/2X7oG16 "The documents include an FDA review of Johnson & Johnson's tests of a second dose of its own vaccine and a separate preprint study that tested mixing booster doses from different companies. The data could provide a road map for the 15 million people who received Johnson & Johnson vaccine in the United States, many of whom have felt left out because the vast majority of U.S. vaccine recipients received messenger RNA vaccines from Pfizer-BioNTech or Moderna." The preprint: https://ift.tt/3BACal0
Hacker News story: Heterologous SARS-CoV-2 Booster Vaccinations: Preliminary Report
![Hacker News story: Heterologous SARS-CoV-2 Booster Vaccinations: Preliminary Report]()
Reviewed by Tha Kur
on
October 13, 2021
Rating:
No comments: